BREAKING NEWS Finally Feeling Like Fall Full Story

FDA's vaccine advisers to discuss rules for authorizing Covid-19 shots for kids

Vaccine advisers to the US Food and Drug Administration will meet Thursday to discuss what information the agency should ask for in considering the go-ahead...

Posted: Jun 9, 2021 4:45 PM
Updated: Jun 9, 2021 4:47 PM

Vaccine advisers to the US Food and Drug Administration will meet Thursday to discuss what information the agency should ask for in considering the go-ahead for vaccinating children under 12 -- including how many children need to be enrolled in clinical trials and how much safety data will be needed.

Members of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will not be asked to discuss specific vaccines or to vote on any issues, but instead will weigh in on what specific extra information companies will have to provide in seeking authorization or approval for children.

Pfizer's Covid-19 vaccine is currently authorized for people 12 and older in the US. Pfizer said Tuesday it would begin testing its vaccine in children as young as 5 using smaller doses than what is authorized for people 12 and older. The company said its Phase 2/3 trial will enroll up to 4,500 children in the United States, Finland, Poland and Spain.

Pfizer and its partner BioNTech also plan to start testing the vaccine in babies as young as 6 months in the coming weeks. But no approval or authorization is expected for younger children before the new school year starts at the end of summer.

Data about Moderna's Covid-19 vaccine for children as young as 5 will likely be available in September or October, Moderna told CNN, and the company plans to apply soon for FDA authorization for use of its vaccine in youths as young as 12.

The rollout has been quick in the younger age group; more than 3.5 million people ages 12 to 15 have already received at least one dose of the vaccine. Half of those 12 and older have now been fully vaccinated, according to data published Tuesday by the US Centers for Disease Control and Prevention.

But the FDA says it will be seeking more deliberate study for authorizing use of the vaccines in kids 11 and under.

Pfizer has applied for full approval, called a biologics license application or BLA, for its vaccine in people 12 and older. Moderna is expected to. So the committee members will be asked to consider what would be needed both for emergency use authorization in children, and full approval. The FDA has broken the younger children into three groups: 6 to 11, 2 to 6 and six months to 2 years.

"What I think we're going to do with that meeting is we're going to decide what the parameters are for approval -- either through emergency use authorization or for licensure -- for much younger age groups," VRBPAC committee member Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia, told CNN's Jake Tapper last week.

"Do we want a two-month follow up? Do we want a six-month follow up? What level of efficacy are we looking for?" Offit added. "It's those sort of parameters we'll be discussing."

In briefing documents released ahead of Thursday's meeting, the FDA said it's usually acceptable to use what are called immunobridging studies to justify approval or emergency authorization of vaccines in children.

These look for evidence of immunity based on what's seen in adults who have volunteered in clinical trials.

In the case of coronavirus vaccines, the FDA said, it would accept data on neutralizing antibodies -- the virus-attacking immune system proteins that are generated by vaccination. So instead of vaccinating a group of children and waiting to see if any become infected, companies could instead run blood tests to see if the vaccines generated an immune response.

Because Covid-19 has not caused the same level of serious disease in children as it has in adults, the FDA said companies will have to make a strong case for authorizing their use in children.

FDA usually asks for safety data in between 500 and 3,000 children in considering a new pediatric vaccine. "Since Covid-19 vaccines represent a new class of vaccines, with many of the lead candidates based on new platform technologies, an appropriate overall pediatric safety database would approach the upper end of this range," it said in the briefing documents.

"Emergency use authorization of a COVID-19 vaccine for use in pediatric populations would require a determination that the known and potential benefits of the vaccine outweigh the known and potential risks specifically in the age groups being considered for emergency use authorization," the FDA added.

"Therefore, clear and compelling evidence to support the safety of the vaccine would be expected to justify its authorization for emergency use in millions of healthy children."

Experts will be asked to consider the possibility of a phenomenon called vaccine-enhanced disease -- when vaccinated people get sicker when infected than unvaccinated people do. This happened in 2017 with a dengue vaccine used in the Philippines. So far, there's been no evidence coronavirus vaccines can cause this, the FDA noted.

Doctors will also be asked about the possibility of a condition called multisystem inflammatory syndrome in children or MIS-C, which is seen in some kids who have been infected with coronavirus and which is theoretically possible after vaccination, but hasn't been seen yet.

"Finally, the VRBPAC will be asked to discuss circumstances under which emergency use authorization could be considered for age groups within 6 months to 12 years and, in that context, data needed to support benefits of making COVID-19 vaccines available under emergency use authorization and safety data needed to assess risks," the FDA said.

Mississippi Coronavirus Cases

Data is updated nightly.

Cases: 497790

Reported Deaths: 9917
CountyCasesDeaths
Harrison34102530
DeSoto31839398
Hinds31837622
Jackson24314377
Rankin21881388
Lee15427234
Madison14525279
Jones13772241
Forrest13412250
Lauderdale11937314
Lowndes10934185
Lamar10470135
Pearl River9431237
Lafayette8454138
Hancock7697126
Washington7365156
Oktibbeha7111129
Monroe6727174
Warren6642176
Pontotoc6609101
Neshoba6606205
Panola6460131
Marshall6386132
Bolivar6266145
Union596094
Pike5784152
Alcorn5633101
Lincoln5417134
George491879
Scott470998
Tippah465381
Prentiss464181
Leflore4627143
Itawamba4596104
Adams4570119
Tate4546109
Copiah445191
Simpson4421116
Wayne438572
Yazoo438586
Covington427394
Marion4216107
Sunflower4215104
Coahoma4115104
Leake407787
Newton380879
Grenada3692108
Stone358464
Tishomingo356391
Attala330289
Jasper328265
Winston313191
Clay306375
Chickasaw296767
Clarke290694
Calhoun277945
Holmes266987
Smith262550
Yalobusha232647
Tallahatchie225251
Walthall217763
Greene215548
Lawrence211140
Perry204755
Amite203954
Webster201645
Noxubee185340
Montgomery179056
Jefferson Davis170642
Carroll167438
Tunica158639
Benton147438
Kemper141241
Choctaw133026
Claiborne131237
Humphreys129038
Franklin119128
Quitman106227
Wilkinson104539
Jefferson94234
Sharkey64020
Issaquena1937
Unassigned00

Alabama Coronavirus Cases

Cases: 813481

Reported Deaths: 15179
CountyCasesDeaths
Jefferson1139971910
Mobile722271323
Madison51970686
Shelby37279341
Baldwin37069540
Tuscaloosa34934599
Montgomery33953725
Lee23142240
Calhoun22142470
Morgan20639372
Etowah19758496
Marshall18245300
Houston17302405
St. Clair15912337
Cullman15306290
Limestone15202198
Elmore15075284
Lauderdale14143294
Talladega13715272
DeKalb12569259
Walker11085366
Blount10094174
Autauga9893146
Jackson9789180
Coffee9182189
Dale8859181
Colbert8789200
Tallapoosa7044195
Escambia6732127
Covington6682179
Chilton6587160
Russell625958
Franklin5930105
Chambers5559142
Marion4955126
Dallas4882199
Clarke472782
Pike4719105
Geneva4564126
Winston4473101
Lawrence4264117
Bibb421686
Barbour355475
Marengo334089
Monroe330262
Randolph327063
Butler324794
Pickens313882
Henry310965
Hale309187
Cherokee299957
Fayette290679
Washington250951
Cleburne246958
Crenshaw243575
Clay240367
Macon230562
Lamar215846
Conecuh185652
Coosa178538
Lowndes173761
Wilcox167438
Bullock151744
Perry138040
Sumter131038
Greene125544
Choctaw86927
Out of AL00
Unassigned00
Tupelo
Clear
70° wxIcon
Hi: 70° Lo: 44°
Feels Like: 70°
Columbus
Clear
70° wxIcon
Hi: 71° Lo: 46°
Feels Like: 70°
Oxford
Clear
66° wxIcon
Hi: 69° Lo: 41°
Feels Like: 66°
Starkville
Clear
68° wxIcon
Hi: 70° Lo: 45°
Feels Like: 68°
A cold front passing through our area overnight will bring into our area some of the coolest temperatures of the season so far. We will see most of the highs this weekend only in the upper 60s to lower 70s. While overnight lows will drop off down into the 40s Saturday night.
WTVA Radar
WTVA Temperatures
WTVA Severe Weather